You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
立方製藥(003020.SZ):收到鹽酸丙美卡因原料藥上市申請批准通知書
格隆匯 07-29 16:14

格隆匯7月29日丨立方製藥(003020.SZ)公佈,近日,合肥立方製藥股份有限公司收到國家藥品監督管理局下發的鹽酸丙美卡因《化學原料藥上市申請批准通知書》。

鹽酸丙美卡因是一種強效酯類表面麻醉劑,其製劑鹽酸丙美卡因滴眼液臨牀上主要用於眼科表面麻醉等,是一種快速作用的局部麻醉藥。截至公吿日,鹽酸丙美卡因原料藥暫無進口原料藥登記備案,除公司外,國產原料藥目前有五家企業登記備案,登記狀態均為“A”(已批准在上市制劑使用的原料)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account